Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Figueres

4 clinical trials in Figueres, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Figueres at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Figueres

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Hypercholesterolaemia

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enlicitide Chloride
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Figueres

What the registry says about research in the country

01 Cardiovascular Research

Ongoing clinical trials focusing on hypercholesterolemia management and treatment optimization. Research includes comparative studies of novel therapeutic agents and established treatments for cholesterol control.

  • Cholesterol Management Studies
  • Lipid-Lowering Therapies
  • Long-term Treatment Safety

Current investigations examine both the efficacy of new medications and their safety profiles in treating high cholesterol levels, with particular attention to LDL-C reduction outcomes.

02 Therapeutic Comparisons

Research initiatives comparing various cholesterol-lowering medications, including novel compounds against established treatments like ezetimibe and bempedoic acid.

  • Comparative Efficacy Studies
  • Treatment Response Analysis
  • Medication Safety Profiles

Studies focus on measuring treatment effectiveness through detailed analysis of cholesterol level changes and patient response patterns.

03 Extended Treatment Studies

Long-term research examining the sustained effects of cholesterol management therapies in adult patients who have completed initial treatment phases.

  • Long-term Safety Monitoring
  • Treatment Tolerability
  • Extended Efficacy Assessment

These trials evaluate the ongoing safety and effectiveness of treatments in patients requiring extended cholesterol management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.